FDA announces review of birth control pills over serious blood clot risks

FDA announces review of birth control pills over serious blood clot risks | LifeSiteNews.com: The US Food and Drug Administration (FDA) announced Tuesday that they were conducting a safety review of birth control products containing drospirenone, a synthetic female sex hormone or progestin. German pharmaceutical maker Bayer’s oral contraceptives Yaz, Yasmine, Safyral, Beyaz, and their generics are part of a chemical family of contraceptives containing drospirenone, and are among the oral contraceptives whose effects the FDA intends to review.